Skip to main content

Advertisement

Open Peer Review Reports for: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
10 Aug 2017 Submitted Original manuscript
15 Sep 2017 Reviewed Reviewer Report - Daniel Kantor
9 Mar 2018 Reviewed Reviewer Report - Theodore Johnson
18 Apr 2018 Reviewed Reviewer Report - Diane L. Cookfair
1 May 2018 Author responded Author comments - Marcus Drake
Resubmission - Version 2
1 May 2018 Submitted Manuscript version 2
25 May 2018 Reviewed Reviewer Report - Diane L. Cookfair
25 Jun 2018 Author responded Author comments - Marcus Drake
Resubmission - Version 3
25 Jun 2018 Submitted Manuscript version 3
12 Jul 2018 Author responded Author comments - Marcus Drake
Resubmission - Version 4
12 Jul 2018 Submitted Manuscript version 4
Publishing
1 Aug 2018 Editorially accepted
6 Aug 2018 Article published 10.1186/s12883-018-1114-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement